Please login to the form below
BenevolentAI raises $115m to fund drug development
Its technology could cut the early stage drug discovery process by four years, says the company
Shire rebuffs Takeda bids, as Allergan bows out
Allergan doesn’t intend to make a formal offer following a dip in its share prices
Spirit Health Group offers new market access consultancy service
Spirit Access will support the pharmaceutical and device industries
P&G agrees $4.2bn buy of Merck KGaA’s consumer health unit
Will also access Merck’s big-selling Neurobion and the Nasivin nasal decongestant range
Publicis LifeBrands Team win UK young Cannes Lions competition
Tom Wordley and Jon Webb will represent the UK at the competition
Rigel and Ultragenyx claim approvals for rare drugs
Tavalisse and Crysvita are set to treat patients with chronic ITP and XLH, respectively
Amgen and Novartis migraine drug hits the mark again
Aimovig will become the first CGRP receptor-targeting drug if it reaches market
Good Relations win Nuffield Health account
The agency will combine Nuffield Health’s gym and hospital offerings
Sanofi sells European generics to Advent for $2.4bn
The deal will create a new, independent European generics company
The shifting healthcare landscape
-
The power of pharma businesses to drive social changeThe importance of CSR programmes
-
The new basics Innovative products and creative marketing won’t help if our industry fails to address the new basics
-
BMS claims rapid FDA nod for Opdivo plus Yervoy in kidney cancerData shows the combo can improve survival compared to Pfizer’s Sutent
-
Merck’s Keytruda meets survival challenge in NSCLCData showed that almost 70% of patients on the combo were still alive after 12 months
-
The Creative Floor launch portfolio and jobs siteThe site will be exclusive to advertising creatives
-
AZ makes case for first-line Tagrisso therapy in lung cancerData shows the drug improved PFS versus older EGFR inhibitors including Roche’s Tarceva
-
Shire offloads oncology unit to Servier for $2.4bnThe French drugmaker will also acquire Oncaspar and Onivyde as part of the deal
-
AZ taps Ionis for another drug, this time in NASH
Will acquire the US pharma group’s antisense drug in a deal valued up to $330m
-
Sanofi backs vaccines unit with €350m Canadian facilityThe new plant will make paediatric and booster vaccines
Latest appointments
-
Abeona Therapeutics names CEOCarsten Thiel joins the biopharma from Alexion
-
Zelluna Immunotherapy appoints chief technology officer
Arjan Roozen will consolidate the biotech’s manufacturing strategy
-
Sobi poaches Pfizer’s Fredrick WetterlundhHe joins the speciality healthcare group as head of human resources
-
VCCP Health strengthens client service teamAppoints two new account handlers
-
Smith & Nephew name new CEO
Namal Nawana will also become an executive director
Featured jobs
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
-
Senior Medical Writer
-
Great salary and bebefits
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
- Account Manager – Med Comms – London
-
Salary TBC
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
- Senior Account Manager / Account Director
-
Great salary and bebefits
-
Senior Programme Executive
-
Salary TBC
-
Scientific Director
-
Great salary and bebefits
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
-
Senior Medical Writer
-
Great salary and benefits
- Editor – Medical Education Agency – Bucks
-
Salary TBC
Subscribe to our email news alerts
Latest intelligence
- No incentive for a cure
- The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
- Why heading online for scientific meetings can yield greater HCP engagement
- Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
- The threat of antimicrobial resistance
- Why this issue is such a fundamental challenge...
Quick links
Infographics
